Language selection

Government of Canada / Gouvernement du Canada

Search

Guidance document : certificates of supplementary protection.: H164-305/2021E-PDF

"In agreeing to provisionally apply the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada has committed to provide up to two years of sui generis protection for new pharmaceutical products protected by an eligible patent, from the expiry of the patent. Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceuticals, biologics and veterinary drugs"--Introduction, page 7.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.894118&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleGuidance document : certificates of supplementary protection.
Variant title
  • Certificates of supplementary protection
  • CSP guidance document
Publication typeMonograph
Language[English]
Other language editions[French]
Later editionGuidance document :
FormatDigital text
Electronic document
Note(s)
  • Cover title.
  • Issued also in HTML format.
  • "Effective date: 2021/01/06."
  • Issued also in French under title: Ligne directrice : certificats de protection supplémentaire.
Publishing information
  • Ottawa, ON : Health Canada = Santé Canada, 2021.
  • ©2019
Description1 online resource (25 pages)
ISBN9780660367620
Catalogue number
  • H164-305/2021E-PDF
Departmental catalogue number200313
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: